Harnessing the Power of D‐Alpha‐Tocopheryl Polyethylene Glycol Succinate‐Based Nanoparticles for Targeted Breast Cancer Therapy
Authors:
- 6 November 2025
- journal article
- review article
- Published by Wiley in WIREs Nanomedicine and Nanobiotechnology
- Vol. 17 (6) , e70040
Abstract
Breast cancer (BC) continues to be the most common cancer affecting women globally, posing significant therapeutic challenges due to limited therapeutic efficacy, non‐specific drug targeting, systemic toxicity, and the emergence of chemoresistance. These hurdles emphasize the critical need for novel and effective treatment strategies. Nanomedicine has revolutionized cancer therapy, especially D‐alpha‐tocopheryl polyethylene glycol succinate (TPGS)‐based nanoparticles (TPGS‐NPs), which have emerged as a promising strategy due to their enhanced therapeutic potential. TPGS, an amphiphilic derivative of Vitamin E, not only enhances the solubility, stability, and bioavailability of lipophilic drugs but also exhibits intrinsic anti‐BC properties. The incorporation of TPGS into NPs significantly enhances their physicochemical properties. Further, the engineering of TPGS‐NPs with targeting ligands significantly improves their specificity towards cancer cells. Also, TPGS‐NPs show great potential to improve photothermal and photodynamic therapies due to their excellent physicochemical properties. Moreover, TPGS‐NPs demonstrate an excellent ability for gene (plasmid DNA, siRNA, and miRNA) delivery by enhancing stability and transfection efficiency. This review explores the multifaceted role of TPGS and the role of different TPGS‐NPs in circumventing the limitations of conventional chemotherapy in BC treatment. Overall, developing TPGS‐NPs offers a versatile and multifaceted approach to achieve better therapeutic outcomes against BC. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic DiseaseKeywords
This publication has 240 references indexed in Scilit:
- Photodynamic therapy for cancer: mechanisms, photosensitizers, nanocarriers, and clinical studiesMedcomm, 2024
- Advances and applications of nanoparticles in cancer therapyMedComm – Oncology, 2024
- Nanomaterial‐Enabled Photothermal Heating and Its Use for Cancer Therapy via Localized HyperthermiaSmall, 2023
- (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapyMedicinal Research Reviews, 2023
- PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug DeliveryAdvanced Healthcare Materials, 2022
- Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020Cancer Communications, 2021
- Doxorubicin Encapsulated in TPGS‐Modified 2D‐Nanodisks Overcomes Multidrug ResistanceChemistry – A European Journal, 2020
- Breast Cancer TreatmentJAMA, 2019
- Nanoparticles in the clinicBioengineering & Translational Medicine, 2016
- Zwitterionic‐Coated “Stealth” Nanoparticles for Biomedical Applications: Recent Advances in Countering Biomolecular Corona Formation and Uptake by the Mononuclear Phagocyte SystemSmall, 2014